China Nuokang Bio-Pharmaceutical Inc. to Participate in 29th Annual J.P. Morgan Healthcare Conference

BEIJING, Dec. 6, 2010 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) (“Nuokang” or the “Company”), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hospital-based medical products, today announced its participation in the 29th Annual J.P. Morgan Healthcare Conference, to be held January 10-13, 2011 at the Westin St. Francis Hotel in San Francisco. The China Healthcare Track of the conference will be held on January 12, 2010. Management will meet with institutional investors throughout the duration of the conference.

MORE ON THIS TOPIC